Evidence map›Paper›PMID 26638791›Full record

ArticleScientific reports2015

A synthetic modular approach for modeling the role of the 3D microenvironment in tumor progression.

S P Singh, M P Schwartz, E Y Tokuda, Y Luo, R E Rogers, M Fujita, N G Ahn, K S Anseth

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. 3DACS biomaterials science & engineering · 2023
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Making In Vitro Tumor Models Whole Again.Advanced healthcare materials · 2023
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Biomimetic Designer Scaffolds Made of D,L-Lactide-Tissue engineering. Part B, Reviews · 2019
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S P SinghDepartment of Chemical and Biological Engineering and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, Colorado, United States of America.
M P SchwartzDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
E Y TokudaDepartment of Chemical and Biological Engineering and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, Colorado, United States of America.
Y LuoDepartment of Dermatology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
R E RogersCollege of Medicine, Texas A&M Health Science Center, Bryan, Texas, United States of America.
M FujitaDepartment of Dermatology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
N G AhnDepartment of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder, Colorado, United States of America.
K S AnsethDepartment of Chemical and Biological Engineering and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, Colorado, United States of America.

Funding

Predoctoral Training Molecular BiophysicsT32GM065103 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI FALKE, JOSEPH J · 2002 to 2021
$4.3M
Quantitative Analysis of Tumor Cell Migration in Three Dimensioinal MatricesR01CA132633 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI ANSETH, KRISTI S., ZAMAN, MUHAMMAD HAMID · 2008 to 2011
$1.5M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA132633NCI NIH HHS R01 CA132633-02NIGMS NIH HHS T32 GM065103
6 · The paper itself

Abstract

Here, we demonstrate the flexibility of peptide-functionalized poly(ethylene glycol) (PEG) hydrogels for modeling tumor progression. The PEG hydrogels were formed using thiol-ene chemistry to incorporate a matrix metalloproteinase-degradable peptide crosslinker (KKCGGPQG↓IWGQGCKK) permissive to proteolytic remodeling and the adhesive CRGDS peptide ligand. Tumor cell function was investigated by culturing WM239A melanoma cells on PEG hydrogel surfaces or encapsulating cells within the hydrogels, and either as monocultures or indirect (non-contact) cocultures with primary human dermal fibroblasts (hDFs). WM239A cluster size and proliferation rate depended on the shear elastic modulus for cells cultured on PEG hydrogels, while growth was inhibited by coculture with hDFs regardless of hydrogel stiffness. Cluster size was also suppressed by hDFs for WM239A cells encapsulated in PEG hydrogels, which is consistent with cells seeded on top of hydrogels. Notably, encapsulated WM239A clusters and single cells adopted invasive phenotypes in the hDF coculture model, which included single cell and collective migration modes that resembled invasion from human melanoma patient-derived xenograft tumors encapsulated in equivalent PEG hydrogels. Our combined results demonstrate that peptide-functionalized PEG hydrogels provide a useful platform for investigating aspects of tumor progression in 2D and 3D microenvironments, including single cell migration, cluster growth and invasion.

Indexed as

Disease ProgressionModels, BiologicalTumor MicroenvironmentAnimalsCell Line, TumorFemaleHumansHydrogelsMice, NudePolyethylene GlycolsStromal CellsHydrogelsPolyethylene Glycols

Identifiers

PMID26638791
PMCPMC4671067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.